Revenue
$8.19B
Fiscal year ended 2026-01-31Operating income
$1.32B
Fiscal year ended 2026-01-31Free cash flow
$1.40B
Fiscal year ended 2026-01-31Marvell Technology, Inc. (MRVL) reported revenue of $8.19B and net income of $2.67B for the fiscal year ended 2026-01-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Marvell Technology, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Semiconductors & Related Devices.
Income
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Revenue | $8.19B | $5.77B | $5.51B | $5.92B | $4.46B | $2.97B | $2.70B |
| Cost of revenue | $4.01B | $3.39B | $3.21B | $2.93B | $2.40B | $1.48B | $1.34B |
| Gross profit | $4.18B | $2.38B | $2.29B | $2.99B | $2.06B | $1.49B | $1.36B |
| Operating income | $1.32B | -$720.30M | -$567.70M | $238.00M | -$347.70M | -$258.40M | -$243.36M |
| Net income | $2.67B | -$885.00M | -$933.40M | -$163.50M | -$421.00M | -$277.30M | $1.58B |
| Research & development | $2.08B | $1.95B | $1.90B | $1.78B | $1.42B | $1.07B | $1.08B |
| Weighted-average diluted shares | shares 869.70M | shares 865.50M | shares 861.30M | shares 851.40M | shares 796.90M | shares 668.80M | shares 676.09M |
| Pretax income | $3.05B | -$894.70M | -$758.70M | $85.10M | -$483.50M | -$322.20M | $798.38M |
| Income tax expense | $376.50M | -$9.70M | $174.70M | $248.60M | -$62.50M | -$44.90M | -$786.01M |
| Diluted EPS | $3.07 | $-1.02 | $-1.08 | $-0.19 | $-0.53 | $-0.41 | $2.34 |
| Selling, general & administrative | $767.10M | $798.20M | $834.00M | $843.60M | $955.30M | Unavailable | Unavailable |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | $843.60M | $955.30M | $467.20M | $464.58M |
Balance
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.64B | $948.30M | $950.80M | $911.00M | $613.50M | $748.47M | Unavailable |
| Total assets | $22.29B | $20.20B | $21.23B | $22.52B | $22.11B | $10.76B | Unavailable |
| Current assets | $6.46B | $3.12B | $3.06B | $3.28B | $2.49B | $1.62B | Unavailable |
| Total liabilities | $7.98B | $6.78B | $6.40B | $6.88B | $6.41B | $2.33B | Unavailable |
| Current liabilities | $3.22B | $2.03B | $1.81B | $2.39B | $1.39B | $1.08B | Unavailable |
| Total equity incl. NCI | $14.31B | $13.43B | $14.83B | $15.64B | $15.70B | $8.44B | $8.68B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $1.39B | $1.03B | $864.40M | $1.07B | $720.30M | $268.23M | Unavailable |
| Accounts receivable | $2.19B | $1.03B | $1.12B | $1.19B | $1.05B | $536.67M | Unavailable |
| Goodwill | $11.06B | $11.59B | $11.59B | $11.59B | $11.51B | $5.34B | Unavailable |
| Long-term debt | $3.97B | $3.93B | $4.06B | $3.91B | $4.48B | $993.17M | Unavailable |
| Accounts payable | $1.07B | $622.20M | $411.30M | $465.80M | $461.50M | $252.42M | Unavailable |
Cash flow
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.75B | $1.68B | $1.37B | $1.29B | $819.30M | $817.30M | $360.30M |
| Capital expenditures | $354.10M | $284.60M | $336.30M | $206.20M | $169.20M | $106.80M | $81.92M |
| Investing cash flow | $2.10B | -$300.70M | -$350.50M | -$328.40M | -$3.75B | -$119.60M | $558.85M |
| Financing cash flow | -$2.16B | -$1.38B | -$980.20M | -$662.90M | $2.79B | -$596.80M | -$853.95M |
| Net change in cash | $1.69B | -$2.50M | $39.80M | $297.50M | -$135.00M | $100.90M | $65.19M |
| Stock-based compensation | $590.80M | $597.40M | $609.80M | $552.40M | $460.70M | $241.50M | $242.21M |
| Common dividends paid | $205.10M | $207.50M | $206.80M | $204.40M | $191.00M | $160.60M | $159.57M |
| Common share repurchases | $2.04B | $725.00M | $150.00M | $115.00M | $0 | $25.20M | $364.27M |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | $304.90M | $265.90M | $197.90M | $156.66M |
Derived
| Metric | 2026-01-31 | 2025-02-01 | 2024-02-03 | 2023-01-28 | 2022-01-29 | 2021-01-30 | 2020-02-01 |
|---|---|---|---|---|---|---|---|
| Free cash flow | $1.40B | $1.40B | $1.03B | $1.08B | $650.10M | $710.50M | $278.38M |
| Gross margin | 51.0% | 41.3% | 41.6% | 50.5% | 46.3% | 50.1% | 50.3% |
| Operating margin | 16.1% | -12.5% | -10.3% | 4.0% | -7.8% | -8.7% | -9.0% |
| FCF margin | 17.0% | 24.2% | 18.8% | 18.3% | 14.6% | 23.9% | 10.3% |
| SBC / revenue | 7.2% | 10.4% | 11.1% | 9.3% | 10.3% | 8.1% | 9.0% |
| Current ratio | 2.01x | 1.54x | 1.69x | 1.37x | 1.80x | 1.50x | Unavailable |
| Revenue YoY growth | 42.1% | 4.7% | -7.0% | 32.7% | 50.3% | 10.0% | Unavailable |
| Net margin | 32.6% | -15.3% | -16.9% | -2.8% | -9.4% | -9.3% | 58.7% |
| R&D / revenue | 25.3% | 33.8% | 34.4% | 30.1% | 31.9% | 36.1% | 40.0% |
| CapEx / revenue | 4.3% | 4.9% | 6.1% | 3.5% | 3.8% | 3.6% | 3.0% |
| Long-term debt / equity | 0.28x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 12.4% | Unavailable | Unavailable | 292.1% | Unavailable | Unavailable | -98.5% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MRVL in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-28View SEC filing
10-Q · Filed 2026-05-28View SEC filing
10-K · Filed 2026-03-11View SEC filing
10-Q · Filed 2025-12-03View SEC filing
10-Q · Filed 2025-08-29View SEC filing
10-Q · Filed 2025-05-30View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.